# Clinical Effect and Safety of PDT and RFA for Unresectable EHCC

> **NCT04301999** · NA · COMPLETED · sponsor: **First People's Hospital of Hangzhou** · enrollment: 67 (actual)

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **PROCEDURE:** Photodynamic therapy
- **PROCEDURE:** radiofrequency ablation

## Key facts

- **NCT ID:** NCT04301999
- **Lead sponsor:** First People's Hospital of Hangzhou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2021-08-27
- **Final completion:** 2021-08-27
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04301999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04301999, "Clinical Effect and Safety of PDT and RFA for Unresectable EHCC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04301999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*